RE: Re: 50p9 Jun 2020 06:28
Hi Max, generally I would not recommend averaging down, but on this occasion we have 3 good things working for us:
1 We seem to be able to maintain an sp above 7p, that is we can maintain a support level for the first time in years.
2 We have an expected pipeline of news and updates
3 Because of the recent licencing agreements ValiRx has a potential income stream to fund product development rather than just relying on constant share issue which caused so much bad feeling.
Averaging down remains a risky strategy, but given the above it's definitely worth considering. GLA.